Table 1. Medians and interquartile ranges of histopathological features of steatosis, ballooning, and inflammation as well as NAS of regimen treated C57BL/6, CD-1, and 129Sv mice.

Strain	Factor	untreated	HF	EtOH			HF + EtOH
			7 weeks	12 weeks	14 weeks	16 weeks	5 weeks	7 weeks	9 weeks
C57BL/6	Steatosis	0 (0–0)	1 (0–1)	1 (0.5–1)	1* (1–1)	1 (0–1)	0 (0–0)	1 (0–1)	0 (0–1)
	Ballooning	0 (0–0)	2* (1.5–2)	0 (0–0)	0 (0–0)	0 (0–0)	0 (0–0)	0 (0–0.5)	2 (0.5–2)
	Inflammation	0 (0–1)	0 (0–0.5)	1 (0.5–1.5)	1 (1–2.5)	2 (0.5–2)	0 (0–0)	1 (0.5–1)	1 (0–2)
	NAS	0 (0–1)	3* (2–3)	2 (1.5–2)	2 (2–3.5)	2 (1–3)	0 (0–0)	2 (1–2)	3* (2.5–3)
CD-1	Steatosis	0 (0–0)	0 (0–0.5)	0 (0–0)	1 (0–1)	0 (0–0.5)	0 (0–0.5)	0 (0–0)	0 (0–0)
	Ballooning	0 (0–0)	0 (0–0)	0 (0–0)	0 (0–0)	0 (0–0)	0 (0–0)	0 (0–0)	1 (0–1.5)
	Inflammation	0 (0–0)	0 (0–1.5)	0 (0–1)	1 (0–1.5)	2 (1–2)	1 (0.5–1.5)	0 (0–1.5)	1 (0.5–2)
	NAS	0 (0–0)	1 (0–1.5)	0 (0–1)	1 (0.5–2.5)	2* (1–2.5)	1 (0.5–2)	0 (0–1.5)	2 (0.5–3.5)
129Sv	Steatosis	0 (0–0)	1 (1–1)	1 (1–1)	1 (1–1)	1* (1–1.8)	1 (0.5–1)	1 (0.5–1)	1 (0.5–1)
	Ballooning	0 (0–0)	0 (0–0)	0 (0–0)	0 (0–0)	0 (0–0)	0 (0–0)	0 (0–0)	0 (0–0)
	Inflammation	0 (0–1)	1 (0–1)	3 (0.75–3)	2.(0.5–2)	2.5* (2–3)	0 (0–1)	2 (1.5–2)	2 (2–2.5)
	NAS	0 (0–1)	2 (1–2)	4* (1.75–4)	3 (1.5–3)	3.5* (3–4.75)	1 (1–1.5)	3 (2–3)	3* (2.5–3.5)

* differences to untreated group were considered significant for P values of <0.05 by Kruskal-Wallis followed by Dunns test of selected pairs of columns